Clinical Trial

Evolution of Chronic Inflammatory Skin Diseases

Study acronym: EPICA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
monocentric retrospective-prospective observational study evaluating the clinical evolution of common chronic inflammatory skin diseases, including atopic dermatitis, psoriasis, prurigo nodularis, chronic hand eczema, and hidradenitis suppurativa. The study will collect demographic, clinical, therapeutic, and validated clinimetric data from patients aged ≥12 years. Its primary aim is to describe changes in disease severity over time. Secondary objectives include identifying demographic, clinical, and treatment-related predictors of moderate-to-severe disease and unfavorable outcomes. Data will cover a 7-year retrospective period and a 10-year prospective follow-up.
Trial Details
NCT Number NCT07708896
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Inflammatory Skin Disease
Enrollment 5,000 participants
Start Date 2026-07
Primary Completion 2030-07 (estimated)
Study Completion 2036-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-16